| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/20/1992 | WO1992013889A1 Nematode vaccine |
| 08/20/1992 | WO1992013884A1 Liver-stage-specific peptide sequences of p. falciparum bearing epitopes capable of stimulating the t lymphocytes |
| 08/20/1992 | WO1992013871A1 Polypeptides and polynucleotides useful for the diagnosis and treatment of pathogenic neisseria |
| 08/20/1992 | WO1992013867A1 Domains of extracellular region of human platelet derived growth factor receptor polypeptides |
| 08/20/1992 | WO1992013553A2 Method and agents for promoting wound healing |
| 08/20/1992 | WO1992013525A1 Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems |
| 08/20/1992 | WO1992010514A3 Synthetic antigens for the detection of antibodies to hepatitis c virus |
| 08/20/1992 | WO1992007940A3 Bovine respiratory syncytial virus genes |
| 08/20/1992 | WO1992006113A3 Derivatives of gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant |
| 08/20/1992 | CA2638662A1 Specific peptidic sequences of p. falciparum heptatic stages that carry epitopes capable of stimulating t lymphocytes |
| 08/20/1992 | CA2103893A1 Monoclonal antibodies against receptor-induced binding sites |
| 08/20/1992 | CA2103676A1 Method and agents for promoting wound healing |
| 08/20/1992 | CA2079871A1 Vaccine |
| 08/20/1992 | CA2079870A1 Vaccine |
| 08/19/1992 | EP0499555A1 Recombinant DNA coding for a T-cell receptor chain, process for preparation and antibodies and pharmaceutical compositions comprising the same |
| 08/19/1992 | EP0499161A2 GM-CSF inhibiting antibodies |
| 08/19/1992 | EP0499112A1 Antibodies against an IgE receptor |
| 08/19/1992 | EP0499003A1 Polypeptides and peptides, particularly recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis |
| 08/19/1992 | EP0498905A1 Conformational epitopes of human immunodeficiency virus envelope glycoprotein gp120 |
| 08/19/1992 | EP0498856A1 Inhibitor of laminin neurite promoting activity |
| 08/19/1992 | EP0498854A1 Antivenoms and methods for making antivenoms |
| 08/19/1992 | EP0498838A1 Method for synthesizing adenosine phosphate derivatives and derivatives thereby obtained |
| 08/19/1992 | CN1017867B Method of preparing covaluently-modified neutral bacterial poly-saccharides and thereof covalent conjugates of such polysaccharides and immunogenic protein |
| 08/18/1992 | US5140105 Purified and isolated HIV protein; reacts with monoclonal anti-monoclonal-anti-human lymphocyte T4 antibodies |
| 08/18/1992 | US5140048 Aging resistance in animals; food preservatives; administering a carboxyl-containing hydrazide; preventing glycosylation of proteins |
| 08/18/1992 | US5139947 Antigenic noninfectious hiv-producing cloned t cell |
| 08/18/1992 | US5139776 Method for culturing Bordetella pertussis, a pertussis toxoid and a pertussis vaccine |
| 08/18/1992 | CA1306582C Synthetic polypeptides for detecting mycobacterial infections |
| 08/18/1992 | CA1306430C Monoclonal antibody |
| 08/18/1992 | CA1306429C Monoclonal antibodies specific for equine chorionic gonadotrophin |
| 08/18/1992 | CA1306428C Monoclonal antibody specific for a mammary tumor cell surface antigen |
| 08/18/1992 | CA1306414C Affinity enhancement system |
| 08/17/1992 | CA2061134A1 Specific chicken egg antibody and method for its production |
| 08/16/1992 | WO1992014488A1 Structural gene of pneumococcal protein |
| 08/16/1992 | WO1992014360A1 Method of lyophilization and reconstitution of mixtures of nucleated non-mammalian cells and blood matter |
| 08/16/1992 | CA2078004A1 Method of lyophilization and reconstitution of mixtures of nucleated non-mammalian cells and blood matter |
| 08/16/1992 | CA2061266A1 Recombinant dna molecules coding for a sequence of the t-cell antigen receptor, process for its preparation, and antibodies and medicament containing them |
| 08/15/1992 | WO1992014755A1 A NOVEL INTEGRIN SPECIFICITY FOR THE HIV Tat PROTEIN |
| 08/15/1992 | CA2101919A1 Integrin specificity for the hiv tat protein |
| 08/13/1992 | WO1992013560A1 Reagents and methods for identification of vaccines |
| 08/13/1992 | DE4204132A1 New compsns. for vaccination against tumours and auto-immune disorders - contain microorganism cultures obtained from patient's own serum or tissues |
| 08/13/1992 | DE4104240A1 Klonierung eines neuen mitgliedes der familie der fibroblasten-wachstumsfaktoren (fgf)-rezeptoren Receptors cloning of a new member of the family of fibroblast growth factors (FGF) |
| 08/13/1992 | CA2103788A1 Reagents and methods for identification of vaccines |
| 08/12/1992 | EP0498767A2 Chimeric antiidiotypic monoclonal antibodies |
| 08/12/1992 | EP0498658A2 Composition for inducing humoral anergy to an immunogen |
| 08/12/1992 | EP0498470A2 An injectable pharmaceutical composition for the protection of tissue damaged by ischemia |
| 08/12/1992 | EP0498333A2 Preparation of an organospecific substance marked with technetium-99m |
| 08/12/1992 | EP0497997A1 Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems |
| 08/12/1992 | EP0497972A1 Chemiluminescent 3-(substituted adamant-2'-ylidene) 1,2-dioxetanes |
| 08/12/1992 | EP0497904A1 Compositions containing plant-produced glycopolypeptide multimers and methods for their production |
| 08/12/1992 | EP0497897A1 Diagnosis of glomerulonephritis |
| 08/12/1992 | EP0497883A1 Compositions and their use for promoting immunopotentiation |
| 08/12/1992 | EP0497881A1 Methods for evaluating cholesterol metabolism and reagents therefor |
| 08/12/1992 | EP0497866A1 Gastrin releasing peptide receptor |
| 08/12/1992 | EP0225329B1 Non-adjuvenated vaccine |
| 08/12/1992 | CN1063507A Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
| 08/12/1992 | CN1063416A Avirulent microbes and uses therefor:salmonella typhi |
| 08/12/1992 | CA2060741A1 Gm-csf inhibiting oligopeptides |
| 08/12/1992 | CA2059842A1 Ige-receptor-antibodies |
| 08/11/1992 | US5137916 Prevents, food spoilage, protein aging in animals |
| 08/11/1992 | US5137877 Bifunctional linking compounds, conjugates and methods for their production |
| 08/11/1992 | US5137819 Cellulose binding fusion proteins for immobilization and purification of polypeptides |
| 08/11/1992 | US5137807 Method for determining beta-subunit of human prolyl 4-hydroxylase by immunoassay to detect hepatic disease |
| 08/11/1992 | US5137725 Dispersion of lipidic spherules |
| 08/11/1992 | CA1306209C Fused antigen polypeptide |
| 08/11/1992 | CA1306207C Polypeptide and protein products, and process for their production and use |
| 08/11/1992 | CA1306194C Use of amphipathic molecules for radio-imaging and therapy with conjugates of monoclonal or polyclonal antibodies |
| 08/11/1992 | CA1306193C Vaccines for fowl colibacillosis |
| 08/11/1992 | CA1306191C Hiv gp160 aids virus envelope protein-containing strips and use thereof for detection of aids antibody |
| 08/09/1992 | WO1992013946A1 Htlv-i and htlv-ii peptide antigens and methods |
| 08/09/1992 | WO1992013558A1 A composition for inducing humoral anergy |
| 08/07/1992 | CA2060626A1 Chimeric antiidiotypic monoclonal antibodies |
| 08/06/1992 | WO1992013081A1 Antigen-presenting capsid with fusion ms2-coat protein |
| 08/06/1992 | WO1992013078A2 Pasteurella haemolytica glycoprotease gene and the purified enzyme |
| 08/06/1992 | WO1992013074A1 CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN (CRF-bp) |
| 08/06/1992 | WO1992013002A1 Influenza virus vaccine composition having a synergistic effect and containing influenza virus core as an additive |
| 08/06/1992 | WO1992012996A2 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 08/06/1992 | WO1992012994A1 Mixed specificity fusion proteins |
| 08/06/1992 | WO1992012992A2 Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods |
| 08/06/1992 | WO1992012734A1 Anti-growth factor antibodies in the treatment of vascular stenosis |
| 08/06/1992 | WO1992012730A1 A method and a system for enhanced in vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion, and the use of said agents for said purpose |
| 08/06/1992 | CA2101781A1 Pasteurella haemolytica glycoprotease gene and the purified enzyme |
| 08/06/1992 | CA2101065A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 08/06/1992 | CA2097424A1 Corticotropin releasing factor binding protein (crf-bp) |
| 08/05/1992 | EP0497525A2 Pneumococcal polysaccharide conjugate vaccine |
| 08/05/1992 | EP0497524A2 Polysaccharide antigens from streptococcus pneumoniae |
| 08/05/1992 | EP0497275A2 Generation of CD4+ helper T cells with interleukin 2 and interleukin 4 from L-phenylalanine methyl ester treated human peripheral blood cells |
| 08/05/1992 | EP0496875A1 METHODS FOR PRODUCING RNA VIRUSES FROM cDNA |
| 08/05/1992 | EP0496818A1 MONOCLONAL ANTIBODY SPECIFIC FOR IgA RECEPTOR |
| 08/05/1992 | EP0496806A1 Materials and methods for the treatment of foreign tissue |
| 08/05/1992 | EP0496794A1 Non-infectious hiv-1 particles and uses therefor |
| 08/05/1992 | EP0217919B1 Type-specific papillomavirus dna sequences and peptides |
| 08/05/1992 | CN1063227A Use of il-4 to enhance immune response to immunogens in vaccines |
| 08/04/1992 | US5136030 Immunostimulating guanine derivatives, compositions and methods |
| 08/04/1992 | US5136019 Synthetic peptides for diagnosis and prevention of influenza virus infection and their use |
| 08/04/1992 | US5135848 Methods for evaluating cholesterol metabolism and reagents therefor |
| 08/04/1992 | US5135736 Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
| 08/04/1992 | CA1305928C Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes |
| 08/04/1992 | CA1305918C Bacterial antigens, antibodies, vaccines, and methods of manufacture |
| 08/02/1992 | WO1992013876A1 METHOD OF PRODUCING F(ab')2 FRAGMENTS OF IMMUNOGLOBULINS |